T1	Participants 53 89	youth with autism spectrum disorders
T2	Participants 525 608	16 male youth aged 12 to 19 who were diagnosed with Autistic or Asperger's Disorder
T3	Participants 919 982	younger participants aged 12 to 15 who received the lower dose.
T4	Participants 1092 1145	young people diagnosed with autism spectrum disorders
T5	Participants 1315 1359	young people with autism spectrum disorders.
